Demographic | Total (N = 119) | PROMIS ≥35 (n = 55) | PROMIS <35 (n = 64) | P Valuea | |
Age (mean + SD) | 52.2 ± 10.7 | 51.7 ± 11.6 | 52.6 ± 10.0 | 0.619 | |
Gender, n (%) | 0.002 | ||||
Female | 55 (46.2%) | 17 (31.0%) | 38 (59.4%) | ||
Male | 64 (53.8%) | 38 (69.0%) | 26 (40.6%) | ||
Body mass index, n (%) | 0.002 | ||||
Nonobese (<30 kg/m2) | 62 (52.1%) | 37 (67.3%) | 25 (39.1%) | ||
Obese (≥30 kg/m2) | 57 (47.9%) | 18 (32.7%) | 39 (60.9%) | ||
Smoking status, n (%) | 0.996 | ||||
Non-smoker | 106 (89.1%) | 49 (89.1%) | 57 (89.1%) | ||
Smoker | 13 (10.9%) | 6 (10.9%) | 7 (10.9%) | ||
Insurance coverage, n (%) | 0.387 | ||||
Private or WC | 115 (96.6%) | 54 (98.2%) | 61 (95.3%) | ||
Medicare/Medicaid | 4 (3.4%) | 1 (1.8%) | 3 (4.7%) | ||
Ageless CCI, mean ± SD | 0.96 ± 1.0 | 0.84 ± 1.1 | 1.06 ± 1.0 | 0.233 | |
Preoperative PHQ-9, mean ± SD | 6.9 ± 6.6 | 5.4 ± 6.0 | 8.3 ± 6.8 | 0.018 | |
Preoperative diagnoses, n (%)b | |||||
Myocardial infarction | 3 (2.5%) | 2 (3.6%) | 1 (1.6%) | 0.472 | |
Uncomplicated diabetes | 10 (8.4%) | 3 (5.5%) | 7 (11.0%) | 0.282 | |
Complicated diabetes | 2 (1.7%) | 1 (1.8%) | 1 (1.6%) | 0.914 | |
Hypertension | 39 (32.8%) | 16 (29.1%) | 23 (36.0%) | 0.428 | |
Neurologic disease | 2 (1.7%) | 1 (1.8%) | 1 (1.6%) | 0.914 | |
Arthritis | 22 (18.5%) | 7 (12%) | 15 (23.4%) | 0.133 | |
Malignancy | 12 (10.1%) | 5 (9.1%) | 7 (11.0%) | 0.739 |
Boldface indicates statistical significance (P < 0.05).
aP value was calculated using Student t test (continuous), χ 2 (categorical), or Fisher exact test (categorical).
bThere were no patients in our study with a recorded medical history of AIDS, paraplegia, congestive heart failure, peripheral vascular disease, metastatic disease, liver disease, renal failure, chronic obstructive pulmonary disease, or gastrointestinal bleeds.
CCI, Charlson Comorbidity Index; PROMIS, Patient-Reported Outcomes Measurement Information System; SD, standard deviation; WC, workers compensation.